Abbott Intrinsic Value
Abbott (ABBOTINDIA) median intrinsic value is ₹10174.00 from 9 valuation models (range ₹5087–₹15778), vs current price ₹25435.00 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit ABBOTINDIA stock price BSE.
ABBOTINDIA Valuation Methods Summary — DCF, Graham Number & P/E
Abbott intrinsic value across 9 models vs current price ₹25435.00 — upside/downside and value range per method. Also explore ABBOTINDIA price trends to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹15778.40 | ₹12622.72 - ₹18934.08 | -38.0% | EPS: ₹717.20, Sector P/E: 22x |
| Book Value Method | asset | ₹5087.00 | ₹4578.30 - ₹5595.70 | -80.0% | Book Value/Share: ₹2015.71, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹7630.50 | ₹6867.45 - ₹8393.55 | -70.0% | Revenue/Share: ₹3387.14, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹10174.00 | ₹9156.60 - ₹11191.40 | -60.0% | EBITDA: ₹2128.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹10174.00 | ₹8139.20 - ₹12208.80 | -60.0% | CF Growth: 8.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹10058.31 | ₹9052.48 - ₹11064.14 | -60.5% | EPS Growth: 17.5%, Fair P/E: 14.0x |
| Growth Adjusted P/E | growth | ₹11254.40 | ₹10128.96 - ₹12379.84 | -55.8% | Revenue Growth: 9.2%, Adj P/E: 15.7x |
| ROE Based Valuation | profitability | ₹12717.50 | ₹11445.75 - ₹13989.25 | -50.0% | ROE: 36.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹7630.50 | ₹6867.45 - ₹8393.55 | -70.0% | EPS: ₹717.20, BVPS: ₹2015.71 |
ABBOTINDIA Intrinsic Value vs Market Price — All Valuation Models
Abbott fair value range ₹5087–₹15778 vs current market price ₹25435.00 across 9 valuation models. Read ABBOTINDIA dividend growth for the complete payout history and dividend yield track record.
ABBOTINDIA Intrinsic Value Analysis — Undervalued or Overvalued?
Abbott median intrinsic value ₹10174.00, current price ₹25435.00 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of ABBOTINDIA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Abbott (ABBOTINDIA) is ₹10174.00 (median value). With the current market price of ₹25435.00, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹5087.00 to ₹15778.40, indicating ₹5087.00 - ₹15778.40.
Is ABBOTINDIA undervalued or overvalued?
Based on our multi-method analysis, Abbott (ABBOTINDIA) appears to be trading above calculated value by approximately 60.0%.
ABBOTINDIA Financial Health — Key Ratios vs Industry Benchmarks
Abbott financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 17.12 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 36.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.20x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ABBOTINDIA Cash Flow Quality — Operating & Free Cash Flow
Abbott operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1,012 Cr | ₹1,012 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹1,213 Cr | ₹1,005 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹893 Cr | ₹819 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹948 Cr | ₹750 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹727 Cr | ₹691 Cr | Positive Free Cash Flow | 8/10 |